Gilles Guillon Selected Research

Gilles Guillon Research Topics

2	Hypoxia (Hypoxemia) 01/2023 - 09/2008
2	Autistic Disorder (Autism) 01/2021 - 07/2015
2	Hyponatremia 11/2016 - 01/2008
2	Septic Shock (Toxic Shock Syndrome) 09/2013 - 03/2009
1	Myocardial Infarction 01/2023
1	Cardiogenic Shock 01/2023
1	Hyperglycemia 01/2017
1	Fibrosis (Cirrhosis) 11/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2016
1	Hepatorenal Syndrome 11/2016
1	Movement Disorders (Movement Disorder) 01/2016
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 07/2015
1	Mood Disorders (Mood Disorder) 01/2012
1	Reperfusion Injury 06/2005
1	Anxiety Disorders (Anxiety Disorder) 09/2003
1	Infections 08/2003

5	Vasopressins (Vasopressin)IBA 01/2023 - 09/2008
2	TerlipressinIBA 11/2016 - 03/2009
2	Oxytocin (Pitocin)FDA LinkGeneric 07/2015 - 09/2013
1	ProdrugsIBA 11/2016
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 11/2016
1	Dopamine D3 ReceptorsIBA 01/2016
1	FE 201874IBA 09/2013
1	Arginine Vasopressin (Argipressin)IBA 09/2013
1	Vasodilator Agents (Vasodilators)IBA 09/2013
1	CatecholaminesIBA 03/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2008
1	lixivaptanIBA 01/2008
1	conivaptan (Vaprisol)FDA Link 01/2008
1	Tolvaptan FDA Link 01/2008
1	satavaptanIBA 01/2008
1	peptide VIBA 01/2008
1	AngiotensinsIBA 06/2005
1	Angiotensin IIIBA 06/2005
1	ReninIBA 06/2005
1	1- (5- chloro- 1- ((2,4- dimethoxyphenyl)sulfonyl)- 3- (2- methoxyphenyl)- 2- oxo- 2,3- dihydro- 1H- indol- 3- yl)- 4- hydroxy- N,N- dimethyl- 2- pyrrolidinecarboxamideIBA 09/2003
1	Anti-Anxiety Agents (Anxiolytics)IBA 09/2003
1	Antidepressive Agents (Antidepressants)IBA 09/2003
1	AldosteroneIBA 08/2003

1	Controlled Hypotension 09/2013